Abstract: CC chemokine receptor 5 (CCR5) is a major coreceptor for cell entry of human immunodeficiency virus (HIV); its expression is highly associated with virus replication and susceptibility. Single nucleotide polymorphisms (SNPs) in the CCR5 promoter play a critical role in CCR5 transcriptional regulation. HHA and HHE represent two contrasting haplotypes of CCR5 with only two base pair differences in the promoter. Identifying the transcription factors (TFs) that differentially bind to the polymorphic sites (the SNPs) in CCR5 haplotypes aids understanding HIV transmission/pathogenesis. Promoter trapping and two-dimensional southwestern blot analysis, to purify transcription complex and identify the differential TFs binding profile, is combined with HPLC-ESI-MS/MS, to determine those proteins specifically bound to one haplotype. This strategy reveals clear differences in haplotype-TF binding and has great promise for investigating how the CCR5 haplotypes may affect HIV-AIDS (acquired immune deficiency syndrome) susceptibility or disease progression.
entry. Differences in CCR5 expression may be mediated through transcriptional, translational/post-translational and epigenetic mechanisms. It has been determined that there is significant inter-individual variation of CCR5 expression on HIV target cells. There are several causes for this variation. Several polymorphisms in the open reading frame (ORF) and promoter region of CCR5 have been found to be associated with CCR5 surface expression on specific cell types. For example, a 32-bp deletion (∆32) in the CCR5 coding region causes loss of CCR5 expression, thus resisting HIV entry. [3] [4] [5] Polymorphisms in the noncoding promoter region of CCR5 have been shown to also play roles in CCR5 promoter activity. These also affect CCR5 expression, and are associated with inter-individual differences in HIV-AIDS susceptibility in vivo, 6 virus replication, 7, 8 virus transmission, and disease progression [9] [10] [11] and influence antiviral therapy. 12 However, the molecular mechanism of these promoter SNPs in CCR5 expression is unclear.
We have previously used an evolutionary based strategy to organize the SNPs in the cis-regulatory region and CCR5-Δ32 mutation in the ORF region of CCR5 into one of seven groups of human haplotypes from HHA to HHG (HHA, HHB, HHC, HHD, HHE, HHF and HHG). 10, 13 Among them, HHE (303A/627C) and HHA (303G/627T) are two typical haplotypes with mutation at sites 303 and 627 in the promoter region of CCR5. The HHE/HHE genotype is associated with an increased risk of acquiring HIV, a faster rate of disease progression to AIDS, increased CCR5 expression on T cell surface, but not monocytes, and reduced cell mediated immunity. In contrast, HHA is the ancestral haplotype and is common in subjects of African descent. This haplotype is found to be associated with the lowest CCR5 transcriptional activity and slower disease progression in HIV 1 African Americans. The HHC haplotype was associated with slower AIDS progression rates in European Americans. In addition, CCR5 haplotypes are associated with cell-type specific effects, resulting in altered expression in specific cell types. A previous study has shown that Oct-1 binding to 627T site on HHA haplotype, although bioinformatics prediction cannot predict this binding site due to the very similar sequences between haplotypes.
In the current study, HHA and HHE, which result in two contrasting phenotypes, are used as a model to explore how CCR5 promoter polymorphisms mediate their effects by influencing transcription factors (TFs) binding. This will help to elucidate further inter-individual difference and variable HIV-AIDS susceptibility. Since the HHA and HHE haplotypes differ in only two base pairs, it is hard to predict TFs binding to the SNPs sites by bioinformatics analysis (as we mentioned above).
In order to identify the differential TFs binding to SNPs in CCR5 promoter, promoter trapping (PT) is first used to purify the transcription complex bound by the HHA or HHE variant promoters individually. In this technique, the promoter DNA is tailed with a single-stranded (GT) 5 at each 3'-end. After incubating tailed promoter DNA with cellular nuclear extract, a transcription complex is formed, which can be trapped by annealing to a (CA) 5 single strand coupled to Sepharose beads and the bound proteins are eluted with high salt buffer. 14 The PT purified transcription complex contains not only specific transcription factors, which interact with response elements on a promoter, but also contains a pre-initiation complex which is composed of general transcription factor II family members (A, B, D, E, F, H) and RNA polymerase II subunits as well as mediators, a total of over 60 protein subunits. To identify the specific transcription factors bound with the promoters, the transcription complexes were further purified two-dimensional gel electrophoresis. To detect only the specific transcription factors, southwestern blots (2D-SW) were then used to compare the promoter binding profiles.
To perform 2D-SW, proteins are separated by two-dimensional gel electrophoresis (2-DE) and the proteins on the gel are transferred to a PVDF membrane. The proteins on the blot are renatured and probed with nanomolar concentrations of radiolabeled promoter DNA (either HHA or HHE) to localize the high affinity DNA binding proteins, which are the transcription factors. The protein spots showing intensity variation, because of different binding affinities with that promoter DNA haplotype on the 2D-SW blot will be taken as differential TFs binding to SNPs of CCR5 promoter. As proteins bind with promoter DNA in 2D-SW analysis at 1.5 nM concentration of DNA probe, most of the unspecific, low affinity binding proteins are removed from consideration, such as pre-initiation complex components, chromatin remodeling proteins and RNA binding proteins. Next, the differentially bound proteins on 2D-SW blot were identified by on-blot trypsin digestion coupled with HPLC-ESI-MS/MS. Thus, identifying the different TFs will help elucidate how the protein-DNA interaction influences differential CCR5 transcription activity and differential CCR5 expression.
Methods
All oligonucleotides were obtained from Integrated DNA Technologies (Coralville, IA, USA). Poly dI:dC, dithiothreitol (DTT), iodoacetamide (IDA), zwittergent 3-16, acetonitrile (ACN) and Tris were from Sigma-Aldrich (St. Louis, MO, USA). Nitrocellulose (NC), polyvinylidene fluoride (PVDF) membranes, sodium dodecylsulfate (SDS), urea, thiourea, ampholyte, IPG strips and other gel electrophoresis reagents were from BioRad Laboratories (CA, USA). Lambda exonuclease was from New England Biolabs (Ipswich, MA, USA). Pol II (N-20) and TFIIF RAP74 (C-18) antibodies were from Santa Cruz Biotechnology (California, USA); SP1 and TBP antibodies were from Upstate Inc. (Chicago, IL, USA). Trypsin (sequencing grade) was from Promega (Madison, WI, USA). 5 tailed CCR5 promoter DNA Tailed CCR5 haplotypes, i.e. HHE and HHA, were prepared as previously reported. 14 Briefly, HHE and HHA promoter DNA was first amplified separately from pGL3-HHA or pGL3-HHE plasmids by using two pairs of primers shown below: 5'-ttcagatag attatatctg gagtg-3' and 5'-Phos-acacacacac cagatgagctgtgcaaatc-3' , which is modified at 5'-end by phosphorylation. The other pair of primers are: 5'-cagatgagctgtgcaaatc-3' and 5'-Phos-acacacacac ttcagatag attatatctg-3' which is also 5'-end phosphorylated. All PCR products were purified from primers by using a QIAquick PCR purification kit (Qiagen, Valencia, CA, USA). The two PCR products of about 800 bp were digested individually with lambda exonuclease and one strand of each PCR product was degraded because it has 5' end phosphorylation, thus producing a single strand DNA (ssDNA) with a (GT) 5 tail at the 3' end. Once two ssDNAs with (GT) 5 tails, representing an upper and lower strand, were annealed, the tailed duplex can further be purified by (CA) 5 affinity chromatography because only (GT) 5 tailed HHA or HHE will bind (CA) 5 -Sepharose beads. To perform this, two PCR products after lambda exonuclease digestion were combined in equal amounts and annealed (1 ml), then diluted into 10 ml TE0.1 buffer (10 mM Tris, pH7.5, 1 mM EDTA, 0.1 M NaCl) for affinity chromatography using a 1 ml bed volume (CA) 5 -Sepharose column at 4° C. The tailed DNA bound on the column was eluted with TE buffer (10 mM Tris, pH7.5, 1 mM EDTA) containing 0.1% Tween-20 at 50°C. After DNA concentration was determined, DNA was stored at 220° C for later use.
Preparation of (GT)
2.2 Preparation of nuclear extract. Jurkat cells were cultured in RPMI1640 containing 10% fetal bovine serum as described previously. 15 Jurkat cells were stimulated with phorbol-12-myristylate-13-acetate (PMA, 25ng/ml) and Ionomycin (500 ng/ml) for 30 minutes and then was used. PMBC were harvested from buffy coats of normal donors and were stimulated by anti-CD3/CD28 antibodies as described previously. 15 Nuclear extracts were prepared as described. 16 
Promoter trapping chromatography.
Promoter trapping was performed as previously described with little modification.
14 500 μg (100 μl) nuclear extract was mixed with (GT) 5 tailed HHA or HHE promoter DNA (50 nM final) in 500 μl incubation buffer (10 mM HEPES, pH 7.9, 50 mM NaCl, 10 mM MgCl 2 , 0.1 mM EDTA, 1 mM DTT, 0.1% Tween-20) containing poly dI:dC (10 ng/μl). The mixture was incubated at 4° C for 30 min to form the transcription complex, then the mixture passed over a 100 μl (CA) 5 -Sepharose column (36 nmol DNA/ml beads) to allow the protein-DNA complex to be trapped on the column. The column was washed with 20 column volumes of incubation buffer, and proteins bound on the column were eluted with TE0.4 buffer (10 mM Tris, pH 7.5, 1 mM EDTA, 0.4 M NaCl). Eluate was desalted and concentrated using an Amicon concentrator (10 kDa cut off).
2.4 Western blotting analysis. Gels were electroblotted onto 0.2 μm pore PVDF membranes (BioRad, Hercules, CA, USA). The dilution of primary antibody is as follows: 1:500 RAP74 (C-18) and 1:2000 RNA polymerase II and TBP antibodies. Immunoreactive proteins are visualized by using 1:10,000 diluted goat anti rabbit or by using 1:5,000 diluted goat anti mouse secondary antibody-HRP conjugate (SouthernBiotech, Birmingham, AL, USA) as appropriate and detected by chemiluminescence (SuperSignal @ West Dura Extended Duration Substrate, Thermo Fisher Scientific, Rockford, IL).
2.5 Two-dimensional southwestern blot (2D-SW) analysis to locate Dna binding proteins. 2D-SW was performed as previously reported with little modification. 17 (17) Briefly, nuclear extract (150 μg) was mixed with rehydration buffer (7 M urea, 2 M thiourea, 2% CHAPS, 65 mM DTT, 0.8% Ampholytes, 1% Zwittergent 3-10, 0.01% bromophenol blue) for two-dimensional gel electrophoresis (2-DE). The first dimension was performed using ReadyStrip IPG strips (pH 3-10, linear, 7 cm) in a PROTEAN IEF cell (BioRad), according to the manufacturer's protocol. IEF was separated at 40, 000 v . hr and 20ºC. Then, the strips were equilibrated in equilibration buffer (50 mM Tris-HCl, pH 6.8, 6 M urea, 2% SDS, 30% glycerol, 0.0001% bromophenol blue) containing 2% DTT at room temperature for 15 min, in equilibration buffer containing 2.5% iodoacetamide for 15 min. The strips were transferred to a 12% SDS-PAGE gel for second dimensional electrophoresis using the PROTEAN II xi 2-D (BioRad) cell. After electrophoresis, the gel was transferred to PVDF membrane for southwestern blotting (SW) analysis. Proteins on the 2-DE blot were blocked and renatured in incubation buffer (used for promoter trapping) containing 2.5% non-fat milk at 4° C overnight. After washing the blot thrice with incubation buffer, radiolabeled promoter DNA without a tail (1.5 nM final concentration) was added into incubation buffer containing 0.25% BSA and 10 ng/μl poly dI:dC and probed at 4° C overnight. The washed blot was exposed for autoradiography.
2.6 Protein identification by in-gel or on-blot trypsin digestion and HPlCnanoeSi-MS/MS. The promoter trapping eluate after desalting and concentration was separated by 12% SDS-PAGE, stained by 0.25% Coomassie Brillant Blue R-250. The gel slice was cut into ten equal pieces horizontally and digested in gel with trypsin as previously described. 18 Briefly, the gel pieces were cut into 1 mm 3 1 mm small cubes and destained thrice for 30 minutes with 25 mM NH 4 HCO 3 /50% ACN, reduced with 10 mM DTT in 100 mM NH 4 HCO 3 at 56° C for 1 h and alkylated in the dark with 50 mM iodoacetamide in 100 mM NH 4 HCO 3 at room temperature for 1 h. The gel plugs were dehydrated with 100% ACN, lyophilized by speed vacuum and immersed in 15-20 µL of trypsin (25 ng/µl) in 25 mM NH 4 HCO 3 for digestion at 37° C overnight. Protein spots on 2D-SW blot were digested as previously described with little modification. 19 Briefly, the protein spots were cut from PVDF membrane, wetted with methanol, washed ten times with water, reduced with 10 mM DTT in 100 mM NH 4 HCO 3 at room temperature for 1 hour and alkylated in the dark with 50 mM iodoacetamide in 100 mM NH 4 HCO 3 at room temperature for 1 hour. The proteins on the blot were digested with 25 ng/µl trypsin in 25 mM NH 4 HCO 3 containing 30% ACN and 0.5% Zwittergent 3-16 at 37° C overnight. After digestion, peptides were extracted twice with 5%TFA/ 50%ACN (50 µl). After lyophilization by speed-vacuum, peptides were resuspended into 20 µl of 0.1% TFA and analyzed by capillary HPLC-nano electrospray ionization-tandem mass spectrometry (HPLC-nanoESI-MS/MS) using a Thermo Finnigan linear ion trap mass spectrometer equipped with a nano-ESI source (LTQ-XLS; ThermoFisher, San Jose, CA). On-line HPLC separation of the digests was accomplished with an Eksigent NanoLC reverse phase HPLC. The column was a PicoFrit TM (New Objective; 50 μm i.d.) column packed to 8 cm with C18 adsorbent (Vydac 218MS, 5 μm, 300 Å). The capillary LC gradient was 2-98% of 0.1% formic acid/acetonitrile over 60 min at a flow rate of 300 nL/min. MS conditions were a 2.5 kV ESI voltage, and in data dependent mode the seven most intense ions in the survey scan with an isolation window for MS/MS of 2 were fragmented at 35% relative collision energy and collision-induced dissociation (CID). MS/MS spectra were searched against the human SWISSPROT non-redundant database combined with an in-house transcription factor database (2944 sequences; 1,671,525 residues) based on probability (greater than 95%) and error-tolerant. Precursor ion mass tolerance was set to 1000 ppm and 0.8 Da for product ion mass tolerance, maximum 2 missed cleavages, carbamidomethyl cysteines and oxidized methionines as variable modifications, and an ion score threshold of 20. The proteins with two unique peptide matched were considered as high confidence, sometimes one peptide with a high ion score were also considered.
results
HHA and HHE are contrasting haplotypes, with two base pairs difference (SNPs) between them, in the promoter region of the CCR5 gene. Identifying the differential binding proteins to HHA or HHE will help elucidate transcriptional regulation of CCR5 expression. Two approaches were used to identify the proteins which bind differently to HHA and HHE: one is to combine PT, SDS-PAGE separation, in-gel digestion and HPLC-ESI-MS/MS; another is to couple 2D-SW, on-blot digestion and HPLC-ESI-MS/MS.
To separate the differentially binding proteins, promoter trapping was performed individually to isolate the transcription complexes formed by HHA and HHE promoter DNA and the components in each transcriptional complex were compared. PT purification requires a tailed promoter DNA, i.e., a single strand (GT) 5 tail added to the duplex promoter DNA at its 3' ends. To achieve this, one of paired primers was designed to have an (AC) 5 sequence and a phosphate at the 5' end , which allows that strand to be degraded by Lambda Exonuclease, leaving a single strand with the complement (GT) 5 tail at the 3'-end. The other complementary single strand, also with a (GT) 5 tail at the 3'-end, was synthesized similarly, and the two single strands annealed to give the final product. We took HHE promoter as an example, as shown in Figure 1 , two PCR products about 800 bp long were amplified by using two primer sets separately (Fig. 1) ; one strand of each PCR product, containing a 5'-end phosphate was digested by Lambda Exonuclease which resulted in a single strand with (GT) 5 tail about 400 nucleotides long, indicated by a star in Fig. 1 , it can be seen that a small amount of the double stranded DNA remained after Lambda Exonuclease digestion presumably because the addition of the 5'-end phosphate during synthesis is incomplete. To verify these are single strands (ssDNA they were digested by restriction endonuclease BamH1. Fig. 1 shows that the two single strands cannot be digested by BamH1, but after they were annealed, the annealed double strand was digested into two fragments which are the same as the positive control, showing the two (GT) 5 tailed ssDNAs annealed to form tailed double standed HHE promoter DNA. In order to remove promoter DNA without a (GT) 5 tail, the annealed double strand was passed over a (CA) 5 -Sepharose column since only (GT) 5 tailed promoter DNA is retained on this column by (GT) 5 -(CA) 5 annealing.
The transcriptional complex trapped by PT contains a pre-initiation complex capable of RNA synthesis and specific transcription factors as well as cofactors. (14) As shown in Figure 2 , Western blot analysis shows that pre-initiation complex components, the TATA box binding protein (TBP), RNA polymerase II (pol II) and TF IIF subunit RAP74, were trapped by CCR5 promoter trapping.
As shown in Figure 3 , compared with cell nuclear extract after PT most of the proteins were removed, retaining the DNA binding proteins bound with the CCR5 haplotypes. HHA and HHE PT complexs show similar 2-DE protein profile, with some protein spots that differ in intensity, implicating the differential binding proteins bound to CCR5 haplotypes. However, a complete transcription complex contains over sixty protein subunits and so such protein stained gels are complex.
To localize the differential, high affinity DNA-binding proteins, two-dimensional southwestern blot analysis (2D-SW) was performed. The proteins on a two-dimensional gel (2-DE) were transferred to PVDF membrane and renatured, then probed with 1.5 nM radiolabeled promoter (HHA or HHE) DNA, the proteins interacting with DNA are localized by autoradiography. In Figure 4 , comparing the 2D-SW profiles between the HHA (left panels) and HHE (right panels) haplotypes, we determined the high affinity DNA-binding proteins affected by these two SNPs. The same amount of nuclear extract from Jurkat, stimulated Jurkat or peripheral mononuclear cells (PBMC) were analyzed by 2D-SW probed with radiolabeled HHA or HHE haplotype DNA separately. The HHE binding profiles are similar between stimulated Jurkat and PBMC, but several HHE binding protein spots are diminished in Jurkat nuclear extract. Similarly, less HHA binding protein spots were detected in Jurkat nuclear extract compared with stimulated Jurkat and PBMC. This may indicate that some high affinity DNA-binding proteins Figure 1 . Preparation of (GT) 5 tailed HHE promoter DNA. Panel A: HHE promoter was amplified by PCR using two pairs of primers, one of which is 5' end modified with a phosphate, two PCR product were produced, i.e. HHE1 and HHE2 in separate PCR reactions and both are approximately 800 bp. Panel B: after purification with a PCR clean-up spin column, HHE1 and HHE2 were digested by lambda exonuclease (to digest the unneeded phosphorylated strand) to produce single strands containing a (GT) 5 tail at the 3' end. The ssDNAs were approximately 400 nt., smaller than double stranded HHE (800 bp) and C, can no longer be digested at BamH1 restriction sites located in the HHE promoter. The two tailed single strands were then annealed to form tailed HHE promoter, which was further purified by DNA affinity chromatography by passing over a (CA) 5 -Sepharose column, since only tailed HHE promoter DNA will bind the (CA) 5 -Sepharose beads. The resulting purified, double stranded DNA was digested with BamH1 to show that now two fragments of approximately 500 and 300 bp are produced, clearly different in size from the single strands used for annealing. "1" shows the HHE1 double stranded DNA produced from PCR also digested with BamH1 giving the same restriction products.
affected by these SNPs are absent in the Jurkat nucleus but present in the PBMCs. So for further study, PBMC nuclear extract was used.
We next performed PT from PBMC, separated this on SDS-PAGE, and combined this with MS identification. To identify these differential binding proteins, the same amount of PBMC nuclear extract was used for HHA and HHE promoter trapping and the same amount of PT eluate was separated by SDS-PAGE, shown in Figure 5 . The Coomassie Brilliant Blue stained gel was cut into ten equal slices for in-gel digestion Figure 2 . Western blot analysis of HHA and HHE trapping of Jurkat nuclear extract. Jurkat nuclear extract was incubated with HHA and HHE promoter DNA containing (GT) 5 tails to form transcription complexes and then the complex was trapped on an (AC) 5 column by promoter trapping (PT). The HHE PT fractions were analyzed by Western blotting against RNA pol II (A), TFIIF RAP74 (B). TBP (C) was compared between HHA and HHE trapping. FT, flow through; W, wash fractions of trapping, i.e. W1 and W2; E1-3, elute fraction 1 to 3; ½ crude, half as much of the initial Jurkat nuclear extract. The molecular weight standards are shown on the left. by trypsin, the produced peptides were analyzed by C18 reverse phase capillary HPLCnanoESI-MS/MS. MS data was searched against both SWISS-PROT public database and our local Transcription Factor database, and the proteins identified by Transcription Factor database search are shown in Table 1 . The candidate proteins are classified into three groups: 1) Those proteins which bind both HHA and HHE. Most of these are highly abundant DNA and RNA binding proteins. 2) Those proteins which bound only the HHA haplotype. 3) Those proteins which bound only the HHE haplotype. Figure 3 . Silver stain analysis of two-dimensional electrophoresis gel of HHA and HHE promoter trapping. The eluate of Jurkat nuclear extract was separated by twodimensional electrophoresis. The first-dimensional IEF was performed using an IPG strip with pH 5-8 and second dimensional electrophoresis was performed by 12% SDS-PAGE. The molecular weight standards are shown on the left.
Proteins in group 2 and group 3 may be the TFs differentially affected by these two SNPs in the CCR5 promoter. At the same time, the protein spots which interacted with radiolabeled promoter DNA on 2D-SW blot of PBMC (Fig. 4) were cut out for on-blot trypsin digestion and HPLC-ESI-MS/MS identification. Some spots, indicated with circles in Figure 4 , have been successfully identified, as shown in Table 2 . On 2D-SW profile, protein spot 2 interacted strongly with HHA and spot 3 interacted most strongly with HHE DNA and are located at the same position; database search indicates them to be interferon regulatory factor 7 (IRF7) and interferon regulatory factor 5 (IRF5), respectively, protein spot 1 which bound strongly with HHA DNA (Fig. 5) is the protein Jumonji with three peptides matched while protein spot 4 which uniquely bound with HHE DNA was identified as the cAMP-responsive element modulator (CREM). Figure 4 . Two-dimensional southwestern blot analysis (2DE-SW) of Jurkat, stimulated Jurkat and PBMC nuclear extract. The nuclear extract (100 μg) was separated by first-dimensional IEF using an IPG strip with pH 3-10 and second dimensional 12% SDS-PAGE electrophoresis. The proteins on the 2-DE gel were transferred to PVDF membrane and renatured in 2.5% non-fat milk in incubation buffer at 4° C overnight, then probed with radiolabeled HHA (left panels) or HHE (right panels) promoter DNA (1.5 nM) and autoradiography. The molecular weight standards are shown on the left. The protein spots circled were further identified by on-blot digestion coupled with HPLC-nanoESI-MS/MS analysis in Table 2 .
Discussion
CCR5 expression levels vary in individuals, which is associated with different HIV-AIDS susceptibility and outcome. In this study, we explore the mechanism by which CCR5 expression is regulated by differentially binding TFs affected by two SNPs in the CCR5 promoter. Previous studies have shown the SNPs sites in CCR5 promoter region or coding region affect CCR5 expression, but the transcriptional mechanism was not elucidated. We hypothesize that differentially binding TFs are affected by these SNPs to regulate CCR5 promoter activity and expression differently. In this manuscript, we use promoter trapping, two-dimensional southwestern blot coupled with HPLC-nanoESI-MS/MS to analyze the differentially binding of proteins to two CCR5 haplotypes, HHA PT eluate of HHA and HHE was separated by 12% SDS-PAGE and stained by coomassie brilliant blue, shown in Figure 5 . The proteins in gel were digested and identified by HPLC-ESI-MS/MS. The candidate proteins after transcription factor database search were compared between HHA and HHE PT in this table. Figure 4 were cut out for on-blot digestion and HPLC-ESI-MS/MS. The identified TFs were shown in In this study, promoter trapping was performed to purify the transcription complex formed by HHA or HHE haplotypes. Western blot analysis showed the presence of expected pre-initiation complex proteins such as RNA polymerase II (pol II), TATA box binding protein (TBP) and TFIIF subunit RAP74, which were all detected after promoter trapping. HPLC-nanoESI-MS/MS analysis of the PT eluate indicates that there are still a many proteins bound with the promoter. This was expected due to the large number of proteins which make up a transcription complex. PT removed many others, which are presumably not involved in transcription.
Some abundant proteins were found to bind both HHA and HHE, i.e., a SWI/SNF complex subunit, ATP-dependent chromatin remodeling proteins; some RNA binding proteins such as special AT-rich sequence binding protein, AT-rich interactive domaincontaining protein 2, U4/U6.U5 tri-snRNP-associated protein 1 and cold shock domaincontaining protein E1, which may confound the identification of very low abundance TFs. Although we found there are several TFs detected only in HHA or HHE binding, their matched peptides and sequence coverage are not very high compared with the proteins binding with both haplotypes. Among the identified TFs from PT eluate, five of them are detected in HHA PT and ten of them are detected in HHE PT. It should be pointed here that ESI-tandem MS analysis itself cannot provide enough information for protein quantitation, so the proteins differentially bound to HHA or HHE need further verification using a quantitative MS technique. Currently, stable isotope labeling of amino acid in cell culture (SILAC) is a quantitative proteomics technique which can be used to identify the TFs binding to HHA and HHE with quantifiable differences. We will explore this technique in subsequent publications.
In the identified TFs, protein jumonji and interferon regulatory factor 7 (IRF7) were found to interact with HHA haplotype, while interferon regulatory factor 5 and cAMP-responsive element modulator (CREM) bind the HHE haplotype. The two protein spots at almost the same position on 2D-SW blots of HHA and HHE were determined to be interferon regulatory factor family members: IRF7 and IRF5 individually, indicating the specificity of 2D-SW analysis since IRF7 and IRF5 have 30% identity in amino acid sequence. They are identified by 2D-SW coupled with HPLC-ESI-MS/MS, but not by PT in this study, implying that 2D-SW has the ability to clarify some of the very low abundant TFs. Protein jumonji is identified in both HHA PT and HHA 2D-SW analysis, implying the concordance of the two approaches. Currently, the other protein spots on 2D-SW blots are in the process of identification by on-blot digestion and ESI-MS/MS.
IRF family members play a key role in induction of interferon (IFN), IFN-stimulated genes, and other proinflammatory cytokines at the transcription level. IRF-7 is essential for the induction of IFN-alpha/beta genes by the retroviruses. 21 IFN-alpha has been reported to significantly increase of CCR5 expression on PBMC in both HIV-infected individuals and controls. 22 Recent studies from IRF5 knockout mice have confirmed a critical role for IRF5 in virus-induced type I IFN expression and proinflammatory cytokines IL-6, IL-12, and TNF-α through both histone deacetylases (HDACs) and histone acetyltransferases (HATs) association with IRF5. 23 Among the identified TFs, cAMP response element-binding protein 1(CREB) is detected in PT of HHA while CREB3 is detected in HHE PT, and CREM is found to be interacted with HHE haplotype by 2D-SW analysis. This study shows that CREB family members are involved in CCR5 promoter binding. The CREB family members CREB-1, activating transcription factor 1 (ATF-1) and cAMP-responsive element modulator (CREM) all bind to CRE sequences as homodimers or heterodimers. 24 Previous studies have found CREB to be bound with the ISREs and CRE sites in the CCR5 promoter region and CREB-1 is important inducer of CCR5 promoter activity and involved in transcriptional regulation of CCR5 expression. 25 In conclusion, we have combined PT, 2D-SW with HPLC-ESI-MS/MS to characterize and identify the differentially binding TFs with CCR5 (supplementary figure) haplotypes, i.e., YB2, CREB, jumonji, Elf-1 and recombing binding protein suppressor of hairless are found to bind the HHA haplotype, while zinc finger E-box-binding homeobox 2, CDP, DNA binding protein RFX5, vacuolar protein sorting-associated protein 72, etc. are found to bind the HHE haplotype, these findings verify the hypothesis that CCR5 variation in expression is regulated at the transcription level by specific TFs binding to SNPs in CCR5 promoter. These identified TF candidates may play role in regulating CCR5 promoter activity and CCR5 expression by binding directly to their DNA sites on CCR5 promoter or by protein-protein interaction with TFs bound with CCR5 promoter DNA. Their function in regulating CCR5 promoter activity and CCR5 expression can be explored by knock-in or knock-out strategy. More investigations are needed to clarify the molecular mechanism of identified TFs in CCR5 inter-individual expression difference and susceptibility. 
